Ex Parte Ziyatdinov et alDownload PDFPatent Trial and Appeal BoardSep 21, 201613432519 (P.T.A.B. Sep. 21, 2016) Copy Citation UNITED STA TES p A TENT AND TRADEMARK OFFICE APPLICATION NO. FILING DATE 13/432,519 03/28/2012 38108 7590 09/23/2016 CERMAK NAKAJIMA MCGOWAN LLP 127 S. Peyton Street Suite 210 ALEXANDRIA, VA 22314 FIRST NAMED INVENTOR Mikhail Kharisovich Ziyatdinov UNITED STATES DEPARTMENT OF COMMERCE United States Patent and Trademark Office Address: COMMISSIONER FOR PATENTS P.O. Box 1450 Alexandria, Virginia 22313-1450 www .uspto.gov ATTORNEY DOCKET NO. CONFIRMATION NO. US-413 1432 EXAMINER LEE,JAEW ART UNIT PAPER NUMBER 1656 NOTIFICATION DATE DELIVERY MODE 09/23/2016 ELECTRONIC Please find below and/or attached an Office communication concerning this application or proceeding. The time period for reply, if any, is set in the attached communication. Notice of the Office communication was sent electronically on above-indicated "Notification Date" to the following e-mail address( es): cgoode@cnmiplaw.com ip@cnmiplaw.com scermak@cnmiplaw.com PTOL-90A (Rev. 04/07) UNITED STATES PATENT AND TRADEMARK OFFICE BEFORE THE PATENT TRIAL AND APPEAL BOARD Ex parte MIKHAIL KHARISOVICH, VIKTOR V ASILIEVICH, and MIKHAIL MARKOVICH1 Appeal2014-003823 Application 13/432,519 Technology Center 1600 Before DEMETRA J. MILLS, LORA M. GREEN, and RICHARD J. SMITH, Administrative Patent Judges. SMITH, Administrative Patent Judge. DECISION ON APPEAL This is an appeal under 35 U.S.C. § 134 involving claims to a method for producing a compound that have been rejected as obvious. We have jurisdiction under 35 U.S.C. § 6(b). We affirm. STATEMENT OF THE CASE Background "The present invention relates to the microbiological industry, and specifically to a method for producing an L-cysteine, L-cystine, a derivative 1 According to Appellants, the real party in interest is Ajinomoto Co., Inc. (Appeal Br. 3.) Appeal2014-003823 Application 13/432,519 or precursor thereof or a mixture thereof using a bacterium of Enterobacteriaceae family which has been modified to have enhanced expression of the genes involved in the process of sulphur assimilation." (Spec. ii 2.) Claims on Appeal Claims 12-15 and 18-24 are on appeal. (Appendix A, Appeal Br. 12- 13.) Independent claim 12 is illustrative and reads as follows: 12. A method for producing a compound selected from the group consisting of L-cysteine, L-cystine, derivatives thereof, and precursors thereof, which comprises cultivating an L-cysteine-producing bacterium of Enterobacteriaceae family in a culture medium containing sulphate, and collecting the compound from the culture medium, wherein the bacterium has been modified to have enhanced expression of one or more genes involved in the process of sulphur assimilation, and wherein said one or more genes involved in the process of sulphur assimilation comprise the cysQ gene or the cysDNC genes. Examiner's Rejection Claims 12-15 and 18-24 stand rejected under 35 U.S.C. § 103(a) as unpatentable over Siebelt,2 Neuwald,3 and Sheremet'eva.4 (Ans. 2.) Claims 13-15 and 19-24 were not argued separately, and therefore, as to those claims, we limit our discussion to claim 12, the only independent claim. 2 Siebelt et al., WO 03/006666 A2, published Jan. 23, 2003 ("Siebelt"). 3 Neuwald et al., cysQ, a Gene Needed for Cysteine Synthesis in Escherichia coli K-12 Only during Aerobic Growth, 174 JOURNAL OF BACTERIOLOGY 2, 415-25 (1992) ("Neuwald"). 4 Sheremet'eva et al., US 2006/0286643 Al, published Dec. 21, 2006 ("Sheremet' eva"). 2 Appeal2014-003823 Application 13/432,519 FINDINGS OF FACT We adopt as our own the Examiner's findings and analysis concerning the scope and content of the prior art. The following findings are included for emphasis and reference convenience. FF 1. Siebelt teaches a method for the preparation of L-amino acids comprising fermentation of microorganisms of the Enterobacteriaceae family which produce the desired amino acid, and in which at least one or more of the genes of the cysteine biosynthesis pathway, including cysD, cysN, cysC, and cysH, are enhanced (over-expressed), the method further including isolation of the desired L-amino acid. (Siebelt 44, 11. 1-19 (claim 1 ).) FF 2. The term L-amino acids, as used in Siebelt, includes L-cysteine. (Id. 3' 11. 14--18.) FF 3. Siebelt teaches that "microorganisms of the Enterobacteriaceae family produce L-amino acids ... in an improved manner after enhancement, in particular over-expression, of at least one or more of ... cysD, cysN, cysC ... [and] cysH." (Id. 6, 11. 15-22.) FF 4. The Specification states that "[t]here are many genes involved in the process of sulphur assimilation including the genes involved in sulphate activation (cysD, cysN, cysC) and adenosine 3'-phosphate 5'- phosphosulphate (PAPS) degradation ( cysQ)." (Spec. i-f 5.) FF 5. The Examiner finds that "[a]lthough Siebelt [] do[ es] not mention that cysD, CysN or CysC genes are involved in the process of sulphur assimilation, i.e., sulphate activation, it is an inherent property of cysD, cysN or cysC genes to be involved in such process." (Ans. 3; see FF 4.) 3 Appeal2014-003823 Application 13/432,519 FF 6. The Examiner finds that the art is inconsistent in the nomenclature of the genes involved in the cysteine biosynthesis pathway, and provides the following Table for clarification: l .................................................. J .. §!~-~_g_[L .............................. .L~~-~~Y§J.Q ............................... ~P.P.~~J.§:~J~~§. ....................... J ! A gene encoding i CysH I CysH CysQ I ! Phosphoadenosine i (see p. 10., IL 23· I (see p. 415, 2nc col.) {see p. 2, paragrapr1 I ! phosphosu!fate i 35) I 0005) I i .. !:~~!:!!:'.~§.~§.JP.:~P..§.L ...... L. .................................................... L .......................................................................................................... ! ! Additional i C:,.tsl/CysQ is a I CysQ controls the I ! d!sclosure i NADPH sulfite I levels of CysH I ! ! reductase I (PAPS) I i i {see p. 10., IL 13· I (see p ·416, ·1st wt, I ! i 22) I 1st ara ra h} I (Ans. 5.) FF 7. Siebelt teaches that cysH (i.e. Appellants' cysQ) is a gene of the cysteine biosynthesis pathway. (Siebelt 10, 1. 23-35; FF 6.) FF 8. Neuwald teaches that the cysQ gene is needed for cysteine synthesis and that CysQ helps control the pool of PAPS, or its use in sulfite synthesis. (N euwald Abstract.) ISSUE Whether a preponderance of the evidence of record supports the Examiner's conclusion of obviousness under 35 U.S.C. § 103(a). ANALYSIS We agree with the Examiner's conclusion that claims 12 and 18 would have been obvious to a person of ordinary skill in the art at the time of the invention based on the cited prior art. (Ans. 2-5; FF 1-8.) We address Appellants' arguments below. As an initial matter, we find that claims 12 and 18 are obvious in view of Siebelt for the reasons set forth in the Answer. (FF 1-7.) Moreover, we do not find that N euwald (or Sheremet' eva) are necessary to support the 4 Appeal2014-003823 Application 13/432,519 obviousness rejection of claims 12 and 18. See Jn re Bush, 296 F.2d 491, 496 ( CCP A 1961) (holding that the Board may rely on fewer references than relied upon by the Examiner without designating it as a new ground of rejection). Claim 12 Siebelt Appellants argue that Siebelt "does not disclose or suggest increased expression of the combination of all the three genes of cysDNC cluster or the cysQ gene in a method for producing L-cysteine." (Appeal Br. 6, 8.) We are not persuaded by Appellants' arguments. Claim 12 recites "one or more genes" which comprise "the cysQ gene or the cysDNC genes." (Appeal Br. 12.) Thus, claim 12 does not require enhanced expression of "the combination of all the three genes of cysDNC' as Appellants contend. (Ans. 7.) Consistent with the doctrine of claim differentiation, this construction is further borne out by claim 18, which is indirectly dependent on claim 12 and recites "one or more genes of the cysDNC cluster." (Id.) Claim 18 would be incongruent if claim 12 was limited to the combination of all three cysDNC genes. Although claim 12 does not require increased expression of the cysQ gene, provided one or more genes of cysDNC are expressed, Siebelt also discloses increased expression of the cysQ gene in its process for the preparation of L-amino acids. As the Examiner explains, Siebelt teaches that "over-expression of one or more genes of the cysteine biosynthesis pathway including cysH (Appellants' cysQ) ... improve[s] the production of L-amino acids." (Ans. 10; see also FF 3, 6, and 7.) Siebelt also makes clear 5 Appeal2014-003823 Application 13/432,519 that its reference to L-amino acids, and specifically improved production thereof, includes L-cysteine. (FF 2.) Motivation to Enhance Expression Appellants make several arguments, generally based on Neuwald and the L-cysteine biosynthesis pathway, 5 for example, that a person of ordinary skill in the art would not have been motivated to increase expression of the cysQ gene or the cysDNC genes. (Appeal Br. 8-9.) In particular, as to the increased expression of the cysQ gene, Appellants argue that (Id.) L-cysteine is synthesized via a series of sequential steps using a plurality of enzymes, and hence, the necessary steps for improving L-cysteine production will differ depending on a variety of factors, such as, for example, which step is the rate- limiting step. Therefore, the disclosure in Neuwald that CysQ is beneficial for L-cysteine synthesis does not necessarily mean, nor would this fact suggest to the skilled art worker, that L- cysteine production can be improved by enhancing the expression of cysQ gene. . . . N euv,rald refers to the possibility that CysQ is involved in sulfite generation or that CysQ sequesters or consumes excess PAPS or the like . . . the person or ordinary skill in the art could not have expected that L- cysteine production can be improved by enhancing the expression of cysQ gene based only on the knowledge that CysQ may be involved in one step among many sequential and complicated steps in L-cysteine biosynthesis. Appellants make a similar argument regarding the increased expression of the cysDNC genes; namely, that 5 Figure 1 ofNeuwald illustrates the pathway of cysteine biosynthesis. (Neuwald 416, FIG. 1.) 6 Appeal2014-003823 Application 13/432,519 (Id.) the person of ordinary skill in the art would not have been motivated to choose to increase the expression of the CysDNC genes for the purpose of increasing production of L-cysteine. This is because the rate-limiting feature is simply due to the fact that the equilibrium of the CysDN reaction is strongly guided in the reverse direction, that is, towards ATP synthesis. Therefore, the rate-limiting aspect is not caused by insufficient amounts of CysDN, and so even by increasing CysDN, the equilibrium of the reaction will not be shifted in the forward direction, that is, towards APS generation. Appellants also point to Sekowska6 to argue that "the rate-limiting effect [of the CysDN reaction] is not due to the conversion speed but to the equilibrium constant" and, therefore, "the person of ordinary skill in the art would not have expected that L-cysteine production can be improved by enhancing the expression of cysDNC gene(s)." (Appeal Br. 9-10, citing Sekowska 146, par. bridging left and right cols.) We are unpersuaded by Appellants' arguments. We note that Siebelt teaches and suggests improved production of L-amino acids, including L- cysteine, by increased expression of the cysH (i.e. cysQ) and cysDNC genes. (FF 2, 3.) That teaching alone suggests the subject matter of claim 12. Moreover, Appellants cannot establish nonobviousness by arguing Neuwald separately from Siebelt. See In re Merck & Co., Inc., 800 F .2d 1091, 1097 (Fed. Cir. 1986) (citing In re Keller, 642 F.2d 413, 425 (CCPA 1981)) (nonobviousness cannot be established by attacking references individually where the Examiner bases the rejection on a combination of references). In 6 Sekowska et al., Sulfur Metabolism in Escherichia coli and Related Bacteria: Facts and Fiction, J. MOL. MICROBIOL. BIOTECHNOL 2(2), 145-77 (2000) ("Sekowska"). 7 Appeal2014-003823 Application 13/432,519 addition, we are unpersuaded by Appellants' arguments regarding Neuwald and the pathway for L-cysteine synthesis for the reasons set forth in the Examiner's Answer. (Ans. 6-10.) Teaching Away Appellants argue that Neuwald teaches away from the present invention based on its reference to the possibility "that CysQ is involved in sulfite generation or that CysQ sequesters or consumes excess PAPS or the like." (Appeal Br. 9, citing Neuwald 423-24; see also Reply Br. 4.) In particular, Appellants argue that a person of ordinary skill in the art would therefore not have been motivated to enhance expression of the cysQ gene because they "would have likely concluded from [Neuwald] that if excess PAPS is wasted when L-cysteine is overproduced, L-cysteine production would decrease." (Appeal Br. 9.) We are not persuaded. Siebelt discloses the subject matter of the claimed invention. Appellants have failed to show how the combination of Siebelt and Neuwald criticizes, discredits, or otherwise discourages one of ordinary skill in the art from the subject matter of the claimed invention. See In re Fulton, 391 F.3d 1195, 1201 (Fed. Cir. 2004). Moreover, Appellants' teaching away argument is contradicted by the express teaching of Siebelt that production of L-amino acids, including L-cysteine, is improved by enhancement (over-expression) of cysH ( cysQ). (FF 3.) Furthermore, claim 12 does not require enhanced expression of the cysQ gene. (Appeal Br. 12.) 8 Appeal2014-003823 Application 13/432,519 Claim 18 Claim 18 recites "[t]he method according to claim 15,7 wherein the bacterium has been modified to have enhanced expression of cysQ gene and one or more genes of cysDNC cluster." (Appeal Br. 12.) Appellants argue that "claim 18 limits the claims to a combined use of the cysQ gene and the cysDNC gene(s)," and that the Examiner has failed to explain how the prior art discloses this combination. (Id. 10.) We are not persuaded. Claim 18 clearly recites the combination of the cysQ gene and "one or more" of the genes of the cysDNC cluster. Moreover, given that cysH corresponds to Appellants' cysQ (Ans. 10, FF 6), and Siebelt teaches the combination of cysH with cysD, cysN, and cysC (FF 3), claim 18 would have been obvious to a person of ordinary skill based on the disclosure of Siebelt. CONCLUSION A preponderance of evidence of record supports the Examiner's conclusion that claims 12 and 18 are obvious under 35 U.S.C. § 103(a). Claims 13-15 and 19-24 were not argued separately and fall with claim 12. SUMMARY We affirm the rejection of all claims on appeal. TIME PERIOD FOR RESPONSE No time period for taking any subsequent action in connection with this appeal may be extended under 37 C.F.R. § 1.136(a). AFFIRMED 7 Claim 15 depends on claim 12. (Appeal Br. 12.) 9 Copy with citationCopy as parenthetical citation